Evidence map

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice.

Thiquynhnga Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

53 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32848437